My view
44 million in the bank
250 million for the development of drug in America
180 million share on registry
so
294 million dollars divided by 180 million shares multiplied by 74 percent
assuming the nasdaq listing occurs
$1.20
does not take into account the pipe line of drugs
does not take into account the relenza top up
does not take into account the flu drug sales in japan
this is only a very simplified view and an opinion of mine which should not be used for investment advice
- Forums
- ASX - By Stock
- BTA
- whats the company worth today
whats the company worth today
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)